NCT00639314 Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy Status COMPLETED Phase NA
NCT00638612 AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01) Status COMPLETED Phase PHASE1
NCT00636883 Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00634725 Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE3
NCT00630552 QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00628186 Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy Status COMPLETED Phase NA
NCT00626158 Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers Status COMPLETED Phase PHASE1
NCT00625586 Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00622674 Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00622622 Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00620295 Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00614653 Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00614601 Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00613730 Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint Status TERMINATED Phase PHASE2
NCT00609765 Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors Status TERMINATED Phase PHASE2
NCT00603863 Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00602602 Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00601627 Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00600002 Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT00599833 Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2